Table:
begin	end	state
1	20	cytoplasmic
21	42	transmembrane
43	53	non-cytoplasmic
54	75	transmembrane
76	81	cytoplasmic
82	102	transmembrane
103	111	non-cytoplasmic
112	134	transmembrane
135	142	cytoplasmic
143	162	transmembrane
163	182	non-cytoplasmic
183	205	transmembrane
206	225	cytoplasmic
226	247	transmembrane
248	267	non-cytoplasmic
268	291	transmembrane
292	320	cytoplasmic
321	341	transmembrane
342	357	non-cytoplasmic
358	385	transmembrane
386	396	cytoplasmic
397	417	transmembrane
418	429	non-cytoplasmic

Input:
>WP_110804518.1 NCBI__GCF_003217355.1:WP_110804518.1
MNTPTPQDGGQKRTLLQSLELDTRLLGMIGAFVVICLVFNVITDGRFLTPRNIFNLSIQT
VSVAIMATGMVFVIVTRHIDLSVGAVLAICSSVMGVMQVQLLPQLFGIGHPLVMPLTVLA
GLLTGAAIGALNGWLVGYQRIPAFIVTLGGLLIWRNVGWYLTDGQTVGPLDQTFMLFGGV
EGTVGSALSWGLAIVFSVLAVFGLWRARQAKIHHEFPVKPLWAEGALMATSVAAILGFVA
ILNSYAIPVGRLKREFESRGEVMPEGYVDYFGLPISVLMLVVIVVVMTLVARKTRLGRYI
FAAGGNPDAAELSGINTRMLTVKIFTLMGVLCAISAMVAQARLANHTNDIGSLDELRVIA
AAVIGGTALAGGIGTIYGAVLGAVIMQSLQSGMAMVGVDAPFQNIVVGGVLVLAVWIDIQ
YRKRTGEKV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server